Samer Al Hadidi, MD,MS,FACP (@HadidiSamer) / X

Samer Al Hadidi, MD,MS,FACP

7,396 posts

Samer Al Hadidi, MD,MS,FACP

@HadidiSamer

Associate Professor @utswcancer. Alumni myeloma @UAMSMyeloma, heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders

Dallas, TX

Joined August 2012

Pinned
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
May 17, 2024
Myeloma is a curable malignancy #mmsm Yes it is curable The cure rate is not ideal (not all/most patients are cured)- there is still work to be done to improve We estimate that one out of three patients with standard risk myeloma (vast majority of cases) are cured 🧵
52K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Dec 8, 2024
#ASH24 #mmsm @ASH_hematology Nice algorithm for therapeutic anticoagulation for cancer associated VTE
50K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Jan 22, 2022
#MedTwitter Hungry macrophage👇(can see in macrophage activation syndromes/HLH/Infections/etc) It already ate: ➡️red cells ➡️platelets ➡️monocytes ➡️neutrophils ➡️lymphocyte ⭐️The result is pancytopenia
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Mar 31, 2023
Little Rock, Arkansas just got hit by a major tornado. Many people lost their homes and damage is still to be estimated We are safe and blessed, thank you for all who reached out Please keep all people here in your thoughts and prayers
00:00
57K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Apr 6, 2022
#MedTwitter 🩸Nurse cell in bone marrow ⭐️macrophage surrounded by erythroblasts to supply iron & nutrition to these cells for formation of RBCs
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Dec 25, 2022
#MedTwitter #AcademicTwitter observation on authorship and number of patients enrolled per author/country🧵 Will use this recent paper as example 👇 Assigning authorship maybe a complex process and depend on many other variables but it is interesting to notice the following:
56K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Nov 15, 2024
Excited to share that I was granted promotion and tenure to Associate Professor in the college of Medicine at the University of Arkansas for Medical Sciences , thankful for all the support I received from mentors and colleagues #mmsm @UAMSMyeloma
7.8K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Aug 31, 2025
Excited to be joining the myeloma group at @UTSWMedCenter @utswcancer Grateful for an incredible 4 years with the amazing team at the Myeloma Center in Arkansas @UAMSMyeloma thank you for the mentorship, support, and lifelong friendships. Here's to new beginnings and continued
7.6K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Oct 20, 2021
A personal story about struggles I encountered during my first year of fellowship as I coped with the loss of my father. #ASCOconnection @ASCO ➡️
connection.asco.org
Vacation
Dr. Samer Al Hadidi shares a personal story about the struggles he encountered during his first year of fellowship as he coped with the loss of his father.
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Jun 4, 2023
It is an honor to win the @GoHealio Health Equity Disruptive Innovator Award for 2023 @ASCO #ASCO23 #mmsm #MedTwitter Such a privilege to be recognized, thank you for the nomination and the award. It is a true honor The goal is equitable healthcare for all
14K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Nov 9, 2024
My top 10 #ASH24 abstracts for plasma cell disorders/multiple myeloma #mmsm @ASH_hematology #mmsm 🧵
27K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Mar 2, 2023
Check out our new paper published @BloodAdvances @ASH_hematology and led by our @UAMSintmedicine @FarahMazahreh presented #ASH22 Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis #mmsm ➡️ashpublications.org/bloodadvances/… 🧵
67K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Sep 29, 2023
Grateful for the @Myeloma_Society for receiving young investigator award #mmsm #IMS23 on the work of secondary malignancies in long term transplant patients
8.1K
Samer Al Hadidi, MD,MS,FACP
@HadidiSamer
Feb 25, 2023
#mmsm How do I treat smoldering myeloma? Observation How do I treat “high risk” smoldering myeloma? Observation Why don’t I enroll on most clinical trials of smoldering myeloma? Because they assume that treatment (active control arm) is beneficial 🧵
121K